Skip to main content
4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
8.48
-0.16 (-1.85%)
At close: Mar 6, 2026, 4:00 PM EST
8.50
+0.02 (0.24%)
After-hours: Mar 6, 2026, 7:39 PM EST

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics had revenue of $90.00K in the quarter ending September 30, 2025, with 2,900.00% growth. This brings the company's revenue in the last twelve months to $120.00K, up 605.88% year-over-year. In the year 2024, 4D Molecular Therapeutics had annual revenue of $37.00K, down -99.82%.

Revenue (ttm)
$120.00K
Revenue Growth
+605.88%
P/S Ratio
3,604.56
Revenue / Employee
$529
Employees
227
Market Cap
432.55M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202437.00K-20.69M-99.82%
Dec 31, 202320.72M17.59M562.29%
Dec 31, 20223.13M-14.91M-82.65%
Dec 31, 202118.04M4.43M32.52%
Dec 31, 202013.61M6.63M94.85%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
REGENXBIO 170.44M
Century Therapeutics 113.34M
Assembly Biosciences 37.19M
Entrada Therapeutics 25.42M
Lineage Cell Therapeutics 10.82M
Altimmune 41.00K
vTv Therapeutics 17.00K
Revenue Rankings

FDMT News

More News